Viewing Study NCT04001634


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-28 @ 6:41 PM
Study NCT ID: NCT04001634
Status: COMPLETED
Last Update Posted: 2024-02-26
First Post: 2019-06-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dual Anti-HER2 Therapy (Lapatinib and Trastuzumab) Plus Chemotherapy in HER2-positive MBC
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module